중도-중증 염증성 심상성 여드름 : 시장 인사이트, 역학, 시장 예측(2034년)

Moderate to Severe Inflammatory Acne Vulgaris - Market Insight, Epidemiology, and Market Forecast - 2034

US $ 7,950 ￦ 11,281,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 11,925 ￦ 16,922,000

PDF (2-3 User License)

PDF 보고서를 동일 사업장에서 3명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 15,900 ￦ 22,563,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 23,850 ￦ 33,845,000

PDF (Global License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계의 주요 7개국(미국, 유럽 주요 5개국(EU5 : 프랑스·독일·이탈리아·스페인·영국), 일본)에서 중도·중증 염증성 심상성 여드름의 역학적 동향과 향후 시장 전망에 대해 분석했으며, 질환의 개요 및 시장의 기본 구조, 현재의 치료법과 미충족 요구, 환자 수의 동향 전망, 출시/임상시험중인 치료제의 개요, 세계 전체/각국의 시장 규모(2020-2034년), 주요 시장 촉진·억제요인 등의 정보를 정리하여 전해드립니다.

조사 개요

• 중도·중증 염증성 심상성 여드름 시장은 향후 수년간 이 질환에 대한 인식의 향상과 세계 전체의 의료비 증가에 의해 변화합니다.
• 기업 및 연구기관은 중도·중증 염증성 심상성 여드름 연구개발에 영향을 미칠 가능성이 있는 과제를 평가하고, 기회를 모색하는 작업을 하고 있습니다. 개발중인 치료법은 병태를 치료/개선하기 위한 신규 어프로치에 초점을 맞추고 있습니다.
• 주요 기업은 중도·중증 염증성 심상성 여드름의 치료법 개발에 관여하고 있습니다. 새로운 치료법의 출시는 중도·중증 염증성 심상성 여드름 시장에 큰 영향을 미칠 것입니다.
• 질환 병태의 심층 이해는 중도·중증 염증성 심상성 여드름의 신규 치료제 개발에도 기여합니다.
• 다른 개발 단계(제III상 및 제II상)에서 파이프라인 자산의 상세 분석 및 새로운 동향, 각 파이프라인 제품의 비교 분석(상세 임상 개요, 키 크로스 경쟁, 제품의 발매일·개발 활동 등 포함) 등의 정보가 연구개발 활동의 전체적인 시나리오를 식별하는 것으로 치료 포트폴리오에 관한 의사결정 프로세스에서 클라이언트를 지원합니다.

목차

제1장 주요 인사이트

제2장 중도·중증 염증성 심상성 여드름 : 주요 요약

제3장 중도·중증 염증성 심상성 여드름 : 경쟁 정보 분석

제4장 중도·중증 염증성 심상성 여드름 : 시장 개요

• 중도·중증 염증성 심상성 여드름의 전체적인 시장 점유율(%, 2020년)
• 중도·중증 염증성 심상성 여드름의 전체적인 시장 점유율(%, 2034년)

제5장 중도·중증 염증성 심상성 여드름 : 질환의 배경과 개요

• 서론
• 징후와 증상
• 병태생리
• 위험인자
• 진단 방법

제6장 페이션트·여정

제7장 중도·중증 염증성 심상성 여드름의 역학과 환자 인구

• 역학적 동향 : 주요 조사 결과
• 전제와 이론적 근거 : 주요 7개국
• 역학 시나리오 : 주요 7개국
  • 중도·중증 염증성 심상성 여드름 : 주요 7개국에서 역학 시나리오(2020-2034년)
• 미국의 역학
  • 미국내 중도·중증 염증성 심상성 여드름 역학 시나리오(2020-2034년)
• 유럽 주요 5개국(5EU)의 역학 : 국가별
  • 독일의 역학
  • 프랑스의 역학
  • 이탈리아의 역학
  • 스페인의 역학
  • 영국의 역학
  • 일본의 역학

제8장 치료 알고리즘, 현재의 치료, 의료 행위

• 중도·중증 염증성 심상성 여드름의 치료·관리 방법
• 중도·중증 염증성 심상성 여드름의 치료 알고리즘

제9장 미충족 요구

제10장 중도·중증 염증성 심상성 여드름 치료제의 주요 평가항목

제11장 출시 제품

• 주요 7개국의 출시 제품 리스트
• 약제 명칭 : 기업명
  • 제품 개요
  • 규제 마일스톤
  • 기타 개발 활동
  • 중요한 임상시험
  • 중요한 임상시험 : 개요

제12장 새로운 치료제

• 키 크로스
• 약제 명칭 : 기업명
  • 제품 개요
  • 기타 개발 활동
  • 임상 개발
  • 안전성과 유효성
  • 제품 개요

제13장 중도·중증 염증성 심상성 여드름 : 주요 7개국의 시장 분석

• 주요 조사 결과
• 중도·중증 염증성 심상성 여드름 시장 규모 : 주요 7개국
• 중도·중증 염증성 심상성 여드름 시장 규모 : 주요 7개국, 치료제별

제14장 속성 분석

제15장 주요 7개국 : 시장 전망

• 미국 시장 규모
  • 미국의 중도·중증 염증성 심상성 여드름의 전체적인 시장 규모
  • 미국의 중도·중증 염증성 심상성 여드름 시장 규모 : 치료제별
• 유럽 주요 5개국(EU5) 시장 : 시장 규모와 전망
• 독일 시장 규모
  • 독일의 중도·중증 염증성 심상성 여드름의 전체적인 시장 규모
  • 독일의 중도·중증 염증성 심상성 여드름 시장 규모 : 치료제별
• 프랑스 시장 규모
• 이탈리아 시장 규모
• 스페인 시장 규모
• 영국 시장 규모
  • 영국의 중도·중증 염증성 심상성 여드름의 전체적인 시장 규모
  • 영국의 중도·중증 염증성 심상성 여드름 시장 규모 : 치료제별
• 일본 시장 : 전망
  • 일본 시장 규모

제16장 중도·중증 염증성 심상성 여드름의 액세스와 상환 개요

제17장 KOL의 견해

제18장 시장 촉진요인

제19장 시장 억제요인

제20장 부록

제21장 DelveInsight의 서비스 내용

제22장 면책사항

제23장 DelveInsight 소개

KSA

영문 목차

영문목차

DelveInsight's "Moderate to Severe Inflammatory Acne Vulgaris - Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the Moderate to Severe Inflammatory Acne Vulgaris, historical and forecasted epidemiology as well as the Moderate to Severe Inflammatory Acne Vulgaris market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Moderate to Severe Inflammatory Acne Vulgaris market report provides current treatment practices, emerging drugs, Moderate to Severe Inflammatory Acne Vulgaris market share of the individual therapies, current and forecasted Moderate to Severe Inflammatory Acne Vulgaris market size from 2020 to 2034 segmented by seven major markets. The Report also covers current Moderate to Severe Inflammatory Acne Vulgaris treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.

Geography Covered:

• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2020-2034

Moderate to Severe Inflammatory Acne Vulgaris Disease Understanding and Treatment Algorithm

The DelveInsight Moderate to Severe Inflammatory Acne Vulgaris market report gives a thorough understanding of the Moderate to Severe Inflammatory Acne Vulgaris by including details such as disease definition, symptoms, causes, pathophysiology, diagnosis and treatment.

Diagnosis

This segment of the report covers the detailed diagnostic methods or tests for Moderate to Severe Inflammatory Acne Vulgaris.

Treatment

It covers the details of conventional and current medical therapies available in the Moderate to Severe Inflammatory Acne Vulgaris market for the treatment of the condition. It also provides Moderate to Severe Inflammatory Acne Vulgaris treatment algorithms and guidelines in the United States, Europe, and Japan.

Moderate to Severe Inflammatory Acne Vulgaris Epidemiology

The Moderate to Severe Inflammatory Acne Vulgaris epidemiology division provide insights about historical and current Moderate to Severe Inflammatory Acne Vulgaris patient pool and forecasted trend for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

Key Findings

The disease epidemiology covered in the report provides historical as well as forecasted Moderate to Severe Inflammatory Acne Vulgaris epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2020 to 2034.

Country Wise-Moderate to Severe Inflammatory Acne Vulgaris Epidemiology

The epidemiology segment also provides the Moderate to Severe Inflammatory Acne Vulgaris epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

Moderate to Severe Inflammatory Acne Vulgaris Drug Chapters

Drug chapter segment of the Moderate to Severe Inflammatory Acne Vulgaris report encloses the detailed analysis of Moderate to Severe Inflammatory Acne Vulgaris marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs. It also helps to understand the Moderate to Severe Inflammatory Acne Vulgaris clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases.

Marketed Drugs

The report provides the details of the marketed product available for Moderate to Severe Inflammatory Acne Vulgaris treatment.

Moderate to Severe Inflammatory Acne Vulgaris Emerging Drugs

The report provides the details of the emerging therapies under the late and mid-stage of development for Moderate to Severe Inflammatory Acne Vulgaris treatment.

Moderate to Severe Inflammatory Acne Vulgaris Market Outlook

The Moderate to Severe Inflammatory Acne Vulgaris market outlook of the report helps to build the detailed comprehension of the historic, current, and forecasted Moderate to Severe Inflammatory Acne Vulgaris market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology.

This segment gives a thorough detail of Moderate to Severe Inflammatory Acne Vulgaris market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on annual cost of therapy, inclusion and exclusion criteria's, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, Moderate to Severe Inflammatory Acne Vulgaris market in 7MM is expected to change in the study period 2020-2034.

Key Findings

This section includes a glimpse of the Moderate to Severe Inflammatory Acne Vulgaris market in 7MM.

The United States Market Outlook

This section provides the total Moderate to Severe Inflammatory Acne Vulgaris market size and market size by therapies in the United States.

EU-5 Countries: Market Outlook

The total Moderate to Severe Inflammatory Acne Vulgaris market size and market size by therapies in Germany, France, Italy, Spain, and the United Kingdom is provided in this section.

Japan Market Outlook

The total Moderate to Severe Inflammatory Acne Vulgaris market size and market size by therapies in Japan is also mentioned.

Moderate to Severe Inflammatory Acne Vulgaris Drugs Uptake

This section focusses on the rate of uptake of the potential drugs recently launched in the Moderate to Severe Inflammatory Acne Vulgaris market or expected to get launched in the market during the study period 2020-2034. The analysis covers Moderate to Severe Inflammatory Acne Vulgaris market uptake by drugs; patient uptake by therapies; and sales of each drug.

This helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

Moderate to Severe Inflammatory Acne Vulgaris Pipeline Development Activities

The report provides insights into different therapeutic candidates in Phase II, and Phase III stage. It also analyses Moderate to Severe Inflammatory Acne Vulgaris key players involved in developing targeted therapeutics.

Pipeline Development Activities

The report covers the detailed information of collaborations, acquisition and merger, licensing, patent details and other information for Moderate to Severe Inflammatory Acne Vulgaris emerging therapies.

Reimbursement Scenario in Moderate to Severe Inflammatory Acne Vulgaris

Approaching reimbursement proactively can have a positive impact both during the late stages of product development and well after product launch. In a report, we take reimbursement into consideration to identify economically attractive indications and market opportunities. When working with finite resources, the ability to select the markets with the fewest reimbursement barriers can be a critical business and price strategy.

KOL- Views

To keep up with current market trends, we take KOLs and SME's opinion working in Moderate to Severe Inflammatory Acne Vulgaris domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies treatment patterns or Moderate to Severe Inflammatory Acne Vulgaris market trend. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the market and the unmet needs.

Competitive Intelligence Analysis

We perform Competitive and Market Intelligence analysis of the Moderate to Severe Inflammatory Acne Vulgaris Market by using various Competitive Intelligence tools that include - SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies etc. The inclusion of the analysis entirely depends upon the data availability.

Scope of the Report:

• The report covers the descriptive overview of Moderate to Severe Inflammatory Acne Vulgaris, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
• Comprehensive insight has been provided into the Moderate to Severe Inflammatory Acne Vulgaris epidemiology and treatment in the 7MM
• Additionally, an all-inclusive account of both the current and emerging therapies for Moderate to Severe Inflammatory Acne Vulgaris are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
• A detailed review of Moderate to Severe Inflammatory Acne Vulgaris market; historical and forecasted is included in the report, covering drug outreach in the 7MM
• The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Moderate to Severe Inflammatory Acne Vulgaris market

Report Highlights:

• In the coming years, Moderate to Severe Inflammatory Acne Vulgaris market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market
• The companies and academics are working to assess challenges and seek opportunities that could influence Moderate to Severe Inflammatory Acne Vulgaris R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition
• Major players are involved in developing therapies for Moderate to Severe Inflammatory Acne Vulgaris. Launch of emerging therapies will significantly impact the Moderate to Severe Inflammatory Acne Vulgaris market
• A better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for Moderate to Severe Inflammatory Acne Vulgaris
• Our in-depth analysis of the pipeline assets across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities

Moderate to Severe Inflammatory Acne Vulgaris Report Insights

• Patient Population
• Therapeutic Approaches
• Moderate to Severe Inflammatory Acne Vulgaris Pipeline Analysis
• Moderate to Severe Inflammatory Acne Vulgaris Market Size and Trends
• Market Opportunities
• Impact of upcoming Therapies

Moderate to Severe Inflammatory Acne Vulgaris Report Key Strengths

• 11 Years Forecast
• 7MM Coverage
• Moderate to Severe Inflammatory Acne Vulgaris Epidemiology Segmentation
• Key Cross Competition
• Highly Analyzed Market
• Drugs Uptake

Moderate to Severe Inflammatory Acne Vulgaris Report Assessment

• Current Treatment Practices
• Unmet Needs
• Pipeline Product Profiles
• Market Attractiveness
• Market Drivers and Barriers

Key Questions:

Market Insights:

• What was the Moderate to Severe Inflammatory Acne Vulgaris market share (%) distribution in 2020 and how it would look like in 2034?
• What would be the Moderate to Severe Inflammatory Acne Vulgaris total market size as well as market size by therapies across the 7MM during the forecast period (2024-2034)?
• What are the key findings pertaining to the market across 7MM and which country will have the largest Moderate to Severe Inflammatory Acne Vulgaris market size during the forecast period (2024-2034)?
• At what CAGR, the Moderate to Severe Inflammatory Acne Vulgaris market is expected to grow in 7MM during the forecast period (2020-2034)?
• What would be the Moderate to Severe Inflammatory Acne Vulgaris market outlook across the 7MM during the forecast period (2020-2034)?
• What would be the Moderate to Severe Inflammatory Acne Vulgaris market growth till 2032, and what will be the resultant market Size in the year 2034?
• How would the market drivers, barriers and future opportunities affect the market dynamics and subsequent analysis of the associated trends?

Epidemiology Insights:

• What is the disease risk, burden and unmet needs of the Moderate to Severe Inflammatory Acne Vulgaris?
• What is the historical Moderate to Severe Inflammatory Acne Vulgaris patient pool in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
• What would be the forecasted patient pool of Moderate to Severe Inflammatory Acne Vulgaris in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
• What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Moderate to Severe Inflammatory Acne Vulgaris?
• Out of all 7MM countries, which country would have the highest prevalent population of Moderate to Severe Inflammatory Acne Vulgaris during the forecast period (2020-2034)?
• At what CAGR the population is expected to grow in 7MM during the forecast period (2020-2034)?

Current Treatment Scenario, Marketed Drugs and Emerging Therapies:

• What are the current options for the Moderate to Severe Inflammatory Acne Vulgaris treatment, along with the approved therapy?
• What are the current treatment guidelines for the treatment of Moderate to Severe Inflammatory Acne Vulgaris in the USA, Europe, and Japan?
• What are the Moderate to Severe Inflammatory Acne Vulgaris marketed drugs and their MOA, regulatory milestones, product development activities, advantages, disadvantages, safety and efficacy, etc.?
• How many companies are developing therapies for the treatment of Moderate to Severe Inflammatory Acne Vulgaris?
• How many therapies are developed by each company for Moderate to Severe Inflammatory Acne Vulgaris treatment?
• How many are emerging therapies in mid-stage, and late stage of development for Moderate to Severe Inflammatory Acne Vulgaris treatment?
• What are the key collaborations (Industry - Industry, Industry - Academia), Mergers and acquisitions, licensing activities related to the Moderate to Severe Inflammatory Acne Vulgaris therapies?
• What are the recent novel therapies, targets, mechanisms of action and technologies developed to overcome the limitation of existing therapies?
• What are the clinical studies going on for Moderate to Severe Inflammatory Acne Vulgaris and their status?
• What are the key designations that have been granted for the emerging therapies for Moderate to Severe Inflammatory Acne Vulgaris?
• What are the global historical and forecasted market of Moderate to Severe Inflammatory Acne Vulgaris?

Reasons to buy:

• The report will help in developing business strategies by understanding trends shaping and driving the Moderate to Severe Inflammatory Acne Vulgaris market
• To understand the future market competition in the Moderate to Severe Inflammatory Acne Vulgaris market and Insightful review of the key market drivers and barriers
• Organize sales and marketing efforts by identifying the best opportunities for Moderate to Severe Inflammatory Acne Vulgaris in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
• Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
• Organize sales and marketing efforts by identifying the best opportunities for Moderate to Severe Inflammatory Acne Vulgaris market
• To understand the future market competition in the Moderate to Severe Inflammatory Acne Vulgaris market

Table of Contents

1. Key Insights

2. Executive Summary of Moderate to Severe Inflammatory Acne Vulgaris

3. Competitive Intelligence Analysis for Moderate to Severe Inflammatory Acne Vulgaris

4. Moderate to Severe Inflammatory Acne Vulgaris: Market Overview at a Glance

• 4.1. Moderate to Severe Inflammatory Acne Vulgaris Total Market Share (%) Distribution in 2020
• 4.2. Moderate to Severe Inflammatory Acne Vulgaris Total Market Share (%) Distribution in 2034

5. Moderate to Severe Inflammatory Acne Vulgaris: Disease Background and Overview

• 5.1. Introduction
• 5.2. Sign and Symptoms
• 5.3. Pathophysiology
• 5.4. Risk Factors
• 5.5. Diagnosis

6. Patient Journey

7. Moderate to Severe Inflammatory Acne Vulgaris Epidemiology and Patient Population

• 7.1. Epidemiology Key Findings
• 7.2. Assumptions and Rationale: 7MM
• 7.3. Epidemiology Scenario: 7MM
  • 7.3.1. Moderate to Severe Inflammatory Acne Vulgaris Epidemiology Scenario in the 7MM (2020-2034)
• 7.4. United States Epidemiology
  • 7.4.1. Moderate to Severe Inflammatory Acne Vulgaris Epidemiology Scenario in the United States (2020-2034)
• 7.5. EU-5 Country-wise Epidemiology
  • 7.5.1. Germany Epidemiology
    • 7.5.1.1. Moderate to Severe Inflammatory Acne Vulgaris Epidemiology Scenario in Germany (2020-2034)
  • 7.5.2. France Epidemiology
    • 7.5.2.1. Moderate to Severe Inflammatory Acne Vulgaris Epidemiology Scenario in France (2020-2034)
  • 7.5.3. Italy Epidemiology
    • 7.5.3.1. Moderate to Severe Inflammatory Acne Vulgaris Epidemiology Scenario in Italy (2020-2034)
  • 7.5.4. Spain Epidemiology
    • 7.5.4.1. Moderate to Severe Inflammatory Acne Vulgaris Epidemiology Scenario in Spain (2020-2034)
  • 7.5.5. United Kingdom Epidemiology
    • 7.5.5.1. Moderate to Severe Inflammatory Acne Vulgaris Epidemiology Scenario in the United Kingdom (2020-2034)
  • 7.5.6. Japan Epidemiology
    • 7.5.6.1. Moderate to Severe Inflammatory Acne Vulgaris Epidemiology Scenario in Japan (2020-2034)

8. Treatment Algorithm, Current Treatment, and Medical Practices

• 8.1. Moderate to Severe Inflammatory Acne Vulgaris Treatment and Management
• 8.2. Moderate to Severe Inflammatory Acne Vulgaris Treatment Algorithm

9. Unmet Needs

10. Key Endpoints of Moderate to Severe Inflammatory Acne Vulgaris Treatment

11. Marketed Products

• 11.1. List of Marketed Products in the 7MM
• 11.2. Drug Name: Company Name
  • 11.2.1. Product Description
  • 11.2.2. Regulatory Milestones
  • 11.2.3. Other Developmental Activities
  • 11.2.4. Pivotal Clinical Trials
  • 11.2.5. Summary of Pivotal Clinical Trial

List to be continued in report

12. Emerging Therapies

• 12.1. Key Cross
• 12.2. Drug Name: Company Name
  • 12.2.1. Product Description
  • 12.2.2. Other Developmental Activities
  • 12.2.3. Clinical Development
  • 12.2.4. Safety and Efficacy
  • 12.2.5. Product Profile

List to be continued in report

13. Moderate to Severe Inflammatory Acne Vulgaris: Seven Major Market Analysis

• 13.1. Key Findings
• 13.2. Moderate to Severe Inflammatory Acne Vulgaris Market Size in 7MM
• 13.3. Moderate to Severe Inflammatory Acne Vulgaris Market Size by Therapies in the 7MM

14. Attribute analysis

15. 7MM: Market Outlook

• 15.1. United States: Market Size
  • 15.1.1. Moderate to Severe Inflammatory Acne Vulgaris Total Market Size in the United States
  • 15.1.2. Moderate to Severe Inflammatory Acne Vulgaris Market Size by Therapies in the United States
• 15.2. EU-5 countries: Market Size and Outlook
• 15.3. Germany Market Size
  • 15.3.1. Moderate to Severe Inflammatory Acne Vulgaris Total Market Size in Germany
  • 15.3.2. Moderate to Severe Inflammatory Acne Vulgaris Market Size by Therapies in Germany
• 15.4. France Market Size
  • 15.4.1. Moderate to Severe Inflammatory Acne Vulgaris Total Market Size in France
  • 15.4.2. Moderate to Severe Inflammatory Acne Vulgaris Market Size by Therapies in France
• 15.5. Italy Market Size
  • 15.5.1. Moderate to Severe Inflammatory Acne Vulgaris Total Market Size in Italy
  • 15.5.2. Moderate to Severe Inflammatory Acne Vulgaris Market Size by Therapies in Italy
• 15.6. Spain Market Size
  • 15.6.1. Moderate to Severe Inflammatory Acne Vulgaris Total Market Size in Spain
  • 15.6.2. Moderate to Severe Inflammatory Acne Vulgaris Market Size by Therapies in Spain
• 15.7. United Kingdom Market Size
  • 15.7.1. Moderate to Severe Inflammatory Acne Vulgaris Total Market Size in the United Kingdom
  • 15.7.2. Moderate to Severe Inflammatory Acne Vulgaris Market Size by Therapies in the United Kingdom
• 15.8. Japan Market Outlook
  • 15.8.1. Japan Market Size
  • 15.8.2. Moderate to Severe Inflammatory Acne Vulgaris Total Market Size in Japan
  • 15.8.3. Moderate to Severe Inflammatory Acne Vulgaris Market Size by Therapies in Japan

16. Access and Reimbursement Overview of Moderate to Severe Inflammatory Acne Vulgaris

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

• 20.1. Bibliography
• 20.2. Report Methodology

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

The table of contents is not exhaustive; the final content may vary.

관련자료